3-[4-[(4-amino-1-bicyclo[2.2.2]octanyl)methoxy]-3-fluoro-phenyl]-1-methyl-pyrazolo[3,4-d]pyrimidin-6-amine

ID: ALA4748638

PubChem CID: 129073171

Max Phase: Preclinical

Molecular Formula: C21H25FN6O

Molecular Weight: 396.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1nc(-c2ccc(OCC34CCC(N)(CC3)CC4)c(F)c2)c2cnc(N)nc21

Standard InChI:  InChI=1S/C21H25FN6O/c1-28-18-14(11-25-19(23)26-18)17(27-28)13-2-3-16(15(22)10-13)29-12-20-4-7-21(24,8-5-20)9-6-20/h2-3,10-11H,4-9,12,24H2,1H3,(H2,23,25,26)

Standard InChI Key:  JGBLHVKRSBVZJG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   13.3791  -14.3338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3779  -15.1616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0901  -15.5747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0883  -13.9208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6630  -13.9213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8052  -14.3302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8100  -15.1571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5983  -15.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0797  -14.7363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5905  -14.0686    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8426  -13.2817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8594  -16.1895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3049  -16.8036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5655  -17.5869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3748  -17.7528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9230  -17.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6637  -16.3523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7322  -17.2957    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.6370  -18.5364    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.4458  -18.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7038  -19.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1561  -20.0985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4153  -20.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2195  -21.0477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7723  -20.4330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5127  -19.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4787  -21.8323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6976  -20.2482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3620  -20.2482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  7  2  0
  6  4  2  0
  4  1  1  0
  1  5  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  6  1  0
 10 11  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 15 19  1  0
 19 20  1  0
 21 20  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
 21 28  1  0
 28 29  1  0
 29 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4748638

    ---
  2. Alternative Forms:

    ALA4748638

    ---

Associated Targets(Human)

TLR7 Tclin Toll-like receptor 7 (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR8 Tchem Toll-like receptor 8 (1853 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR9 Tclin Toll-like receptor 9 (943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tlr7 Toll-like receptor 7 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tlr9 Toll-like receptor 9 (360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.47Molecular Weight (Monoisotopic): 396.2074AlogP: 3.18#Rotatable Bonds: 4
Polar Surface Area: 104.87Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.73CX LogP: 2.63CX LogD: -0.23
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.00

References

1. Alper PB,Deane J,Betschart C,Buffet D,Collignon Zipfel G,Gordon P,Hampton J,Hawtin S,Ibanez M,Jiang T,Junt T,Knoepfel T,Liu B,Maginnis J,McKeever U,Michellys PY,Mutnick D,Nayak B,Niwa S,Richmond W,Rush JS,Syka P,Zhang Y,Zhu X.  (2020)  Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway.,  30  (17): [PMID:32738975] [10.1016/j.bmcl.2020.127366]

Source